Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2023 $ 706,415 $ (232) $ (600,658) $ 105,525
Balance, at beginning (in shares) at Dec. 31, 2023 20,926        
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock upon exercise of prefunded warrants (in shares) 113,155        
Issuance of common stock under At-the-market offering, net of transactional expenses of $4,977 $ 4 128,363 128,367
Issuance of common stock under At-the-market offering, net of transactional expenses of $4,977 (in shares) 4,174,122        
Issuance of common stock, net of transactional expenses of $2,261 14,215 14,215
Issuance of common stock, net of transactional expenses of $2,261 (in shares) 77,635        
Fair value of warrants reclassified from liabilities to equity 26,682 26,682
Fair value of warrants classified from equity to liabilities (9,977) (9,977)
Employee stock purchase plan 27 27
Employee stock purchase plan (in shares) 91        
Stock-based compensation 4,778 4,778
Foreign currency transaction gain (23) (23)
Net loss (130,036) (130,036)
Ending balance, value at Dec. 31, 2024 $ 4 870,503 (255) (730,694) 139,558
Balance, at ending (in shares) at Dec. 31, 2024 4,385,929        
Repurchase of common stock under Share Repurchase Program, including transactional expenses of $30 (13,760) $ (13,760)
Repurchase of common stock under Share Repurchase Program, including transactional expenses of $30 (in shares) (847,903)       (847,903)
Issuance of commitment shares 1,837 $ 1,837
Issuance of commitment shares (in shares) 48,708        
Issuance of common stock under At-the-market offering, net of transactional expenses of $7,174 $ 8 217,033 217,041
Issuance of common stock under At-the-market offering, net of transactional expenses of $7,174 (in shares) 8,586,310        
Issuance of common stock and warrants under registered direct Financing, net of transactional expenses of $1,488 $ 1 18,511 18,512
Issuance of common stock and warrants under registered direct Financing, net of transactional expenses of $1,488 (in shares) 615,025        
Stock-based compensation 6,017 6,017
Foreign currency transaction gain (34) (34)
Net loss (124,021) (124,021)
Ending balance, value at Dec. 31, 2025 $ 13 $ 1,100,141 $ (289) $ (854,715) $ 245,150
Balance, at ending (in shares) at Dec. 31, 2025 12,788,069